Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study-Reference-Cited by-同舟云学术

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Published:2016-03 Issue:3 Volume:16 Page:311-320
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

De Santis Olga,Audran Régine,Pothin Emilie,Warpelin-Decrausaz Loane,Vallotton Laure,Wuerzner Grégoire,Cochet Camille,Estoppey Daniel,Steiner-Monard Viviane,Lonchampt Sophie,Thierry Anne-Christine,Mayor Carole,Bailer Robert T,Mbaya Olivier Tshiani,Zhou Yan,Ploquin Aurélie,Sullivan Nancy J,Graham Barney S,Roman François,De Ryck Iris,Ballou W Ripley,Kieny Marie Paule,Moorthy Vasee,Spertini François,Genton Blaise

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference19 articles.

1. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge;Stanley;Nat Med,2014

2. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults;Ledgerwood;Vaccine,2010

3. Chimpanzee adenovirus vector Ebola vaccine—preliminary report;Ledgerwood;N Engl J Med,2014

4. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe—preliminary report;Agnandji;N Engl J Med,2015

5. Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to ad5 and protect nonhuman primates against Ebolavirus challenge;Geisbert;J Virol,2011

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials;npj Vaccines;2024-03-29

2. A Single-shot ChAd3 Vaccine Provides Protection from Intramuscular and Aerosol Sudan Virus Exposure;2024-02-12

3. 12 Vaccine Candidates for Novel Pathogens;Principles and Practice of Emergency Research Response;2024

4. Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Vaccines;2023-12-22

5. Clinical and laboratory features in health care volunteers with inactivated SARS-CoV-2 vaccination;Turkish Journal of Medical Sciences;2023-10-26